SEC 13F Intelligence

Haven Capital Group, Inc. / EW

Haven Capital Group, Inc.’s Edwards Lifesciences Corp Position

Does Haven Capital Group, Inc. own Edwards Lifesciences Corp (EW)? Yes — 44.1K shares worth $4M (+3.27% of its 13F portfolio) as of Q1 2026.

Position Value
$4M
Q1 2026
Shares
44.1K
% of Portfolio
+3.27%
Quarters Held
6
currently held

Position History EW

Reported value by quarter
Q4 ’24: $4MQ4 ’24Q1 ’25: $4MQ1 ’25Q2 ’25: $4MQ2 ’25Q3 ’25: $4MQ3 ’25Q4 ’25: $4MQ4 ’25Q1 ’26: $4MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202644.1K$4M+3.27%
Q4 202544.1K$4M+3.52%
Q3 202549.1K$4M+3.40%
Q2 202550.2K$4M+3.46%
Q1 202551.5K$4M+4.11%
Q4 202452.3K$4M+3.64%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Haven Capital Group, Inc.’s full portfolio or all institutional holders of EW.